DBR ON DATA

Security, Privacy and Information Governance

Tag: HHS

Continued Special Privacy Treatment for Substance Use Disorder Information

Share

The Senate Health, Education, Labor and Pensions Committee recently passed the Opioid Crisis Response Act of 2018 (OCRA) – a bipartisan package of more than 40 proposals designed to help families and entire communities affected by the nation-wide opioid crisis.

Continue reading

New FDA Guidance on Waiver of Informed Consent for Minimal Risk Investigations

Share

The FDA recently issued new guidance that allows institutional review boards (IRBs) to waive or alter the FDA’s informed consent requirements for certain minimal risk clinical investigations without objection from the FDA.

The statutory basis for the guidance comes from amendments made by the 21st Century Cures Act from late in 2016 (P.L 144-255). This guidance, which took effect on July 25, 2017, is the first step for the FDA on this issue.  The FDA intends to implement subsequent regulations to permit IRB waiver or alterations of informed consent requirements for minimal risk clinical investigations.

Continue reading

© 2018 Drinker Biddle & Reath LLP. All Rights Reserved. Lawyer Advertising.

Disclaimer/Privacy Policy